SNAP Form 4: Elizabeth Jenkins awarded 33,157 RSUs, vesting after one year
Rhea-AI Filing Summary
Elizabeth Jenkins, a Snap Inc. director, was granted 33,157 restricted stock units (RSUs) on 08/07/2025, each convertible into one share of Class A common stock at no cash price. The filing shows she beneficially owns 73,563 shares following the award. The RSUs vest 100% after one year of continuous service beginning August 2, 2025, are subject to pro-rata acceleration on discontinued service and full acceleration upon a change in control, and will fully vest if the reporting person dies while in continuous service. The Form 4 was filed individually and signed by an attorney-in-fact on 08/11/2025.
Positive
- Grant of 33,157 RSUs to a director increases the director's stake and aligns interests with shareholders
- Clear vesting and acceleration terms (100% after one year from 08/02/2025, pro-rata on termination, full on change in control) are disclosed
Negative
- None.
Insights
Routine director equity grant; limited immediate market impact but increases insider alignment and disclosed beneficial ownership.
The Form 4 documents an equity award of 33,157 RSUs to director Elizabeth Jenkins, reported as acquired on 08/07/2025, with reported beneficial ownership of 73,563 shares after the grant. The award price is shown as $0.00, consistent with restricted stock unit grants that settle in shares. Vesting is time-based (100% after one year from 08/02/2025) with standard acceleration provisions on termination and change in control. Based solely on the filing, this is a routine corporate governance disclosure rather than a material operational event.
Compensation terms include one-year cliff vesting with pro-rata and change-in-control acceleration; standard director protective provisions.
The explanatory note states the RSUs vest 100% after one year of continuous service from August 2, 2025, will accelerate pro-rata on discontinued board service, automatically vest on a defined change in control, and vest on the reporting person's death during service. These contractual terms align with common director equity practices to retain board members and protect beneficiaries; no additional governance actions or departures are disclosed in this filing.